A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth

被引：79

作者：

Bei, R. ^{[1
]}

Masuelli, L. ^{[2
]}

Palumbo, C. ^{[1
]}

Modesti, M. ^{[3
]}

Modesti, A. ^{[1
]}

机构：

[1] Univ Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy

[2] Univ Sapienza, Dept Expt Med, Rome, Italy

[3] Univ Sapienza, Dept Surg Sci, Rome, Italy

来源：

CANCER LETTERS | 2009年 / 281卷 / 01期

关键词：

Tumor antigens; Anti-cancer immunity; Immune tolerance; Autoantibodies; Inflammation; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTI-DNA ANTIBODIES; B-CELL EPITOPE; RIBOSOMAL-P-PROTEINS; OF-THE-LITERATURE; LUNG-CANCER; P53; AUTOANTIBODIES; IMMUNE-RESPONSE; SELF-ANTIGENS; HEPATOCELLULAR-CARCINOMA;

D O I：

10.1016/j.canlet.2008.11.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The repertoire of autoantibodies found in cancer patients partly overlaps with that typical of patients with autoimmune diseases. Beside the biochemical and immunological properties of the target antigens and their altered expression in tumor tissues, the intratumoral inflammatory context can play a key role in the induction of autoimmune disease-associated autoantibodies in cancer patients. Furthermore, the impact of such antibodies on cancer growth and progression can be deeply influenced by the interplay with inflammation. The characterization of the spontaneous humoral responses occurring in cancer patients, of the mechanisms that trigger and sustain the autoantibody response and of the biological effects of such autoantibodies may help the rational design of anti-cancer immunotherapeutic protocols. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：8 / 23

页数：16

共 172 条

[21] VERY LONG CHARGE RUNS IN SYSTEMIC LUPUS ERYTHEMATOSUS-ASSOCIATED AUTOANTIGENS [J].

BRENDEL, V ;

DOHLMAN, J ;

BLAISDELL, BE ;

KARLIN, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1536-1540

[22] CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer - A case study and review of the literature [J].

Briasoulis, Evangelos ;

Kamposioras, Konstantinos ;

Tzovaras, Vasilis ;

Pafitanis, George ;

Kostoula, Angeliki ;

Mavridis, Anestis ;

Pavlidis, Nicholas .

LUNG CANCER, 2008, 60 (02) :302-306

[23] Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity [J].

Carl, PL ;

Temple, BRS ;

Cohen, PL .

ARTHRITIS RESEARCH & THERAPY, 2005, 7 (06) :R1360-R1374

[24] Screening for Celiac disease in non-Hodgkin's lymphoma patients - A serum anti-transglutaminase-based approach [J].

Carroccio, A ;

Iannitto, E ;

Di Prima, L ;

Cirrincione, S ;

Troncone, R ;

Paparo, F ;

Trapani, LG ;

Gucciardi, A ;

Averna, MR ;

Montalto, G ;

Notarbartolo, A .

DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (08) :1530-1536

[25] Identification of α-fetoprotein as an autoantigen in juvenile Batten disease [J].

Castaneda, Julian A. ;

Pearce, David A. .

NEUROBIOLOGY OF DISEASE, 2008, 29 (01) :92-102

[26]

Castelli M, 2001, ANTICANCER RES, V21, P753

[27] Autoantibodies in breast cancer: their use as an aid to early diagnosis [J].

Chapman, C. ;

Murray, A. ;

Chakrabarti, J. ;

Thorpe, A. ;

Woolston, C. ;

Sahin, U. ;

Barnes, A. ;

Robertson, J. .

ANNALS OF ONCOLOGY, 2007, 18 (05) :868-873

[28] Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes [J].

Chauhan, R ;

Handa, R ;

Das, TP ;

Pati, U .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (03) :574-584

[29]

CODIGNOLA A, 1993, J BIOL CHEM, V268, P26240

[30] Self antigens and epitope spreading in systemic autoimmunity [J].

Craft, J ;

Fatenejad, S .

ARTHRITIS AND RHEUMATISM, 1997, 40 (08) :1374-1382

← 1 2 3 4 5 6 7 8 9 10 →